ANDAORALCONCENTRATE
Approved
Oct 1987
Lifecycle
Post-LOE
Competitive Pressure
30/100
Data completeness
2/8 — Basic
THIOTHIXENE HYDROCHLORIDE (thiothixene hydrochloride) by Teva is actions thiothixene is an antipsychotic of the thioxanthene series. First approved in 1987.
Drug data last refreshed 18h ago
Mechanism of Action
ACTIONS Thiothixene is an antipsychotic of the thioxanthene series. Thiothixene possesses certain chemical and pharmacological similarities to the piperazine phenothiazines and differences from the aliphatic group of phenothiazines.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Company
Teva
Israel - Petach Tikva
Worked on THIOTHIXENE HYDROCHLORIDE at Teva? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.